Literature DB >> 18408239

An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service.

Mark Gilchrist1, Bryony Dean Franklin, Jignesh P Patel.   

Abstract

OBJECTIVES: Administering parenteral antibiotics outside the confines of a ward setting is becoming an attractive way of treating infections in the UK. However, as well as having many advantages, an outpatient parenteral antibiotic therapy (OPAT) service potentially introduces new risks to staff and patients involved. In the United States, healthcare organizations are now prospectively analysing processes to try and prevent errors occurring using the Healthcare Failure Mode Effect Analysis (HFMEA) tool. The objectives of this study were to map out and agree the OPAT process and sub-processes and to identify potential OPAT system failures using steps 1-3 of the HFMEA tool, so that the resulting OPAT map can be used to design an OPAT service where risk is minimized.
METHODS: The study was undertaken using a consensus development panel to which the HFMEA process was applied. Key stakeholders in the local OPAT process were invited to join the HFMEA team with the aim of describing and agreeing (defined as 100% participant agreement) an OPAT map, its sub-processes and potential OPAT system failures.
RESULTS: The HFMEA team identified 6 processes, 67 sub-processes and 217 possible failures over the course of four meetings. Key areas identified in the OPAT map concerned identifying and checking patient suitability for an OPAT service, involvement of a multidisciplinary team and robust communication channels.
CONCLUSIONS: An OPAT map was developed, which may serve as a practical model for other organizations setting up a similar service.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408239     DOI: 10.1093/jac/dkn152

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Outpatient parenteral antimicrobial therapy.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

2.  Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study.

Authors:  D A Barr; L Semple; R A Seaton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-12       Impact factor: 3.267

3.  Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece.

Authors:  G Theocharis; P I Rafailidis; D Rodis; I Kontopidis; S G Barbas; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-02       Impact factor: 3.267

4.  Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting.

Authors:  J Kieran; A O'Reilly; J Parker; S Clarke; C Bergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-21       Impact factor: 3.267

5.  Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care.

Authors:  Anjie Yang; Ron Fung; James Brunton; Linda Dresser
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 6.  Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

Authors:  Ester Steffens; Charlotte Quintens; Inge Derdelinckx; Willy E Peetermans; Johan Van Eldere; Isabel Spriet; Annette Schuermans
Journal:  Infection       Date:  2018-11-15       Impact factor: 3.553

7.  Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence.

Authors:  Eavan G Muldoon; David R Snydman; Elizabeth C Penland; Geneve M Allison
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

8.  Covering more Territory to Fight Resistance: Considering Nurses' Role in Antimicrobial Stewardship.

Authors:  R Edwards; Ln Drumright; M Kiernan; A Holmes
Journal:  J Infect Prev       Date:  2011-01

9.  Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin.

Authors:  Jennifer M Stephens; Xin Gao; Dipen A Patel; Bram G Verheggen; Ahmed Shelbaya; Seema Haider
Journal:  Clinicoecon Outcomes Res       Date:  2013-09-16

Review 10.  Managing an outpatient parenteral antibiotic therapy team: challenges and solutions.

Authors:  Jenana Halilovic; Cinda L Christensen; Hien H Nguyen
Journal:  Ther Clin Risk Manag       Date:  2014-06-18       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.